{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:55:03Z","timestamp":1793735703553,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41433-019-0756-9","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:03:27Z","timestamp":1577991807000},"page":"1685-1692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Management of recurrent sebaceous gland carcinoma"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0925-1124","authenticated-orcid":false,"given":"Lindsay A.","family":"McGrath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanna I.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep Singh","family":"Mudhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H. Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin M.","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"756_CR1","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ophtha.2004.07.031","volume":"111","author":"JA Shields","year":"2004","unstructured":"Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004;111:2151\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2004.07.031.","journal-title":"Ophthalmology"},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0002-9394(86)90214-X","volume":"102","author":"AM Putterman","year":"1986","unstructured":"Putterman AM. Conjunctival map biopsy to determine pagetoid spread. Am J Ophthalmol. 1986;102:87\u201390.","journal-title":"Am J Ophthalmol"},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0046-8177(82)80115-9","volume":"13","author":"NA Rao","year":"1982","unstructured":"Rao NA, Hidayat AA, McLean IW, et al. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982;13:113\u201322.","journal-title":"Hum Pathol"},{"key":"756_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/IOP.0b013e31816d925f","volume":"24","author":"A Song","year":"2008","unstructured":"Song A, Carter KD, Syed NA. et al. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes. Ophthalmic Plast Reconstr Surg. 2008;24:194\u2013200. https:\/\/doi.org\/10.1097\/IOP.0b013e31816d925f.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"756_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000104764","volume":"221","author":"JS Yoon","year":"2007","unstructured":"Yoon JS, Kim SH, Lee CS, et al. Clinicopathological analysis of periocular sebaceous gland carcinoma. Ophthalmologica. 2007;221:331\u20139. 10.1159\/000104764 [published Online First: 2007\/08\/31]","journal-title":"Ophthalmologica"},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bjo.82.9.1049","volume":"82","author":"M Zurcher","year":"1998","unstructured":"Zurcher M, Hintschich CR, Garner A, et al. Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol. 1998;82:1049\u201355.","journal-title":"Br J Ophthalmol"},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/sj.eye.6700523","volume":"18","author":"MM Muqit","year":"2004","unstructured":"Muqit MM, Roberts F, Lee WR. et al. Improved survival rates in sebaceous carcinoma of the eyelid. Eye. 2004;18:49\u201353. https:\/\/doi.org\/10.1038\/sj.eye.6700523.","journal-title":"Eye"},{"key":"756_CR8","doi-asserted-by":"publisher","unstructured":"Sa HS, Tetzlaff MT, Esmaeli B. Predictors of local recurrence for eyelid sebaceous carcinoma: questionable value of routine conjunctival map biopsies for detection of pagetoid spread. Ophthalmic Plast Reconstr Surg. 2019. https:\/\/doi.org\/10.1097\/IOP.0000000000001343.","DOI":"10.1097\/IOP.0000000000001343"},{"key":"756_CR9","doi-asserted-by":"publisher","unstructured":"Sa HS, Rubin ML, Xu S, et al. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol. 2018. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312635.","DOI":"10.1136\/bjophthalmol-2018-312635"},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0161-6420(01)00719-9","volume":"108","author":"AN Chao","year":"2001","unstructured":"Chao AN, Shields CL, Krema H, et al. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001;108:1877\u201383.","journal-title":"Ophthalmology"},{"key":"756_CR11","unstructured":"Carcinoma Skin of the Eyelid. TNM classification of malignant tumours. 8th ed. Wiley-Blackwell; United Kingdom. 2016:136."},{"key":"756_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/IOP.0000000000000013.","volume":"30","author":"B While","year":"2014","unstructured":"While B, Salvi S, Currie Z. et al. Excision and delayed reconstruction with paraffin section histopathological analysis for periocular sebaceous carcinoma. Ophthal Plast Reconstr Surg. 2014;30:105\u20139. https:\/\/doi.org\/10.1097\/IOP.0000000000000013.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"756_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ophtha.2011.11.006","volume":"119","author":"B Esmaeli","year":"2012","unstructured":"Esmaeli B, Nasser QJ, Cruz H. et al. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology. 2012;119:1078\u201382. https:\/\/doi.org\/10.1016\/j.ophtha.2011.11.006.","journal-title":"Ophthalmology"},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0039-6257(89)90049-0","volume":"33","author":"LG Kass","year":"1989","unstructured":"Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989;33:477\u201390.","journal-title":"Surv Ophthalmol"},{"key":"756_CR15","doi-asserted-by":"publisher","unstructured":"Lam SC, Li EYM, Yuen HKL. 14-Year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management. Br J Ophthalmol. 2018. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311533.","DOI":"10.1136\/bjophthalmol-2017-311533"},{"key":"756_CR16","doi-asserted-by":"publisher","unstructured":"Zhou C, Wu F, Chai P, et al. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients. J Am Acad Dermatol. 2019. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.053.","DOI":"10.1016\/j.jaad.2018.12.053"},{"key":"756_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/eye.2015.79","volume":"29","author":"S Kaliki","year":"2015","unstructured":"Kaliki S, Ayyar A, Dave TV. et al. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians. Eye. 2015;29:958\u201363. https:\/\/doi.org\/10.1038\/eye.2015.79.","journal-title":"Eye"},{"key":"756_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajo.2016.08.028","volume":"171","author":"Y Takahashi","year":"2016","unstructured":"Takahashi Y, Takahashi E, Nakakura S. et al. risk factors for local recurrence or metastasis of eyelid sebaceous gland carcinoma after wide excision with paraffin section control. Am J Ophthalmol. 2016;171:67\u201374. https:\/\/doi.org\/10.1016\/j.ajo.2016.08.028.","journal-title":"Am J Ophthalmol"},{"key":"756_CR19","doi-asserted-by":"publisher","unstructured":"Lee IJ, Koh JY Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid\u2014a population-based analysis. Orbit. 2018:1\u20138. https:\/\/doi.org\/10.1080\/01676830.2018.1505922.","DOI":"10.1080\/01676830.2018.1505922"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/APO.0000000000000105","volume":"4","author":"JA Shields","year":"2015","unstructured":"Shields JA, Saktanasate J, Lally SE. et al. Sebaceous carcinoma of the ocular region: The 2014 Professor Winifred Mao lecture. Asia Pac J Ophthalmol. 2015;4:221\u20137. https:\/\/doi.org\/10.1097\/APO.0000000000000105.","journal-title":"Asia Pac J Ophthalmol"},{"key":"756_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ajo.2013.12.009","volume":"157","author":"FA Jakobiec","year":"2014","unstructured":"Jakobiec FA, Werdich X. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas. Am J Ophthalmol. 2014;157:687\u201396 e1-2. https:\/\/doi.org\/10.1016\/j.ajo.2013.12.009.","journal-title":"Am J Ophthalmol"},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jcjo.2014.04.004","volume":"49","author":"K Mulay","year":"2014","unstructured":"Mulay K, White VA, Shah SJ, et al. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol. 2014;49:326\u201332. https:\/\/doi.org\/10.1016\/j.jcjo.2014.04.004 [published Online First: 2014\/08\/12]","journal-title":"Can J Ophthalmol"},{"key":"756_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/DAD.0000000000000255","volume":"37","author":"JA Plaza","year":"2015","unstructured":"Plaza JA, Mackinnon A, Carrillo L, et al. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopathol. 2015;37:809\u201321. https:\/\/doi.org\/10.1097\/DAD.0000000000000255 [published Online First: 2015\/10\/21]","journal-title":"Am J Dermatopathol"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0161-6420(02)01239-3","volume":"109","author":"CL Shields","year":"2002","unstructured":"Shields CL, Naseripour M, Shields JA, et al. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology. 2002;109:2129\u201333. [published Online First: 2002\/11\/05]","journal-title":"Ophthalmology"},{"key":"756_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1442-9071.2009.02048.x","volume":"37","author":"AK Rudkin","year":"2009","unstructured":"Rudkin AK, Muecke JS. Mitomycin-C as adjuvant therapy in the treatment of sebaceous gland carcinoma in high-risk locations. Clin Exp Ophthalmol. 2009;37:352\u20136. https:\/\/doi.org\/10.1111\/j.1442-9071.2009.02048.x [published Online First: 2009\/07\/15]","journal-title":"Clin Exp Ophthalmol"},{"key":"756_CR26","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/bjo.2003.034215","volume":"88","author":"K Tumuluri","year":"2004","unstructured":"Tumuluri K, Kourt G, Martin P. Mitomycin C in sebaceous gland carcinoma with pagetoid spread. Br J Ophthalmol. 2004;88:718\u20139.","journal-title":"Br J Ophthalmol"},{"key":"756_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000018399","volume":"200","author":"T Graefe","year":"2000","unstructured":"Graefe T, Wollina U, Schulz H. et al. Muir-Torre syndrome\u2014treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology. 2000;200:331\u20133. https:\/\/doi.org\/10.1159\/000018399.","journal-title":"Dermatology"},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2004.12.008","volume":"50","author":"JA Shields","year":"2005","unstructured":"Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50:103\u201322. https:\/\/doi.org\/10.1016\/j.survophthal.2004.12.008.","journal-title":"Surv Ophthalmol"},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0161-6420(89)32798-9","volume":"96","author":"RD Lisman","year":"1989","unstructured":"Lisman RD, Jakobiec FA, Small P. Sebaceous carcinoma of the eyelids. The role of adjunctive cryotherapy in the management of conjunctival pagetoid spread. Ophthalmology. 1989;96:1021\u20136.","journal-title":"Ophthalmology"},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ijrobp.2010.12.006","volume":"82","author":"M Hata","year":"2012","unstructured":"Hata M, Koike I, Omura M, et al. Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. Int J Radiat Oncol Biol Phys. 2012;82:605\u201311. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.006.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"756_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/IOP.0000000000000398","volume":"32","author":"S Kaliki","year":"2016","unstructured":"Kaliki S, Ayyar A, Nair AG. et al. Neoadjuvant systemic chemotherapy in the management of extensive eyelid sebaceous gland carcinoma: a study of 10 cases. Ophthal Plast Reconstr Surg. 2016;32:35\u20139. https:\/\/doi.org\/10.1097\/IOP.0000000000000398.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"756_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.12659\/AJCR.912552","volume":"19","author":"SH Lee","year":"2018","unstructured":"Lee SH, Jung YH, Yoo JY. et al. A case report of recurrent metastatic sebaceous carcinoma which showed favorable response Tt non-fluorouracil based chemotherapy. Am J Case Rep.2018;19:1192\u20136. https:\/\/doi.org\/10.12659\/AJCR.912552.","journal-title":"Am J Case Rep."},{"key":"756_CR33","doi-asserted-by":"publisher","unstructured":"Cheung JJC, Esmaeli B, Lam SC, et al. The practice patterns in the management of sebaceous carcinoma of the eyelid in the Asia Pacific region. Eye. 2019. https:\/\/doi.org\/10.1038\/s41433-019-0432-0.","DOI":"10.1038\/s41433-019-0432-0"},{"key":"756_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00002341-199103000-00008","volume":"7","author":"JA Khan","year":"1991","unstructured":"Khan JA, Doane JF, Grove AS Jr. Sebaceous and meibomian carcinomas of the eyelid. Recognition, diagnosis, and management. Ophthal Plast Reconstr Surg. 1991;7:61\u20136.","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0756-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0756-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0756-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:09:52Z","timestamp":1684616992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0756-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0756-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"14 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}